Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Darcy

Showing results (121-130 of 222) with videos related to

Pageof 23
Sort By:
Gynecologic Oncology|November 27, 2007
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancerGillian Thomas, Shamshad Ali, Frank J P Hoebers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Trends in the incidence and mutational landscape of advanced uterine cancerAlex A Francoeur, Cheng-I Liao, Caitlin R Johnson, et al.
British Journal of Cancer|January 10, 2013
Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group StudyS Y Liao, W H Rodgers, J Kauderer, et al.
British Journal of Cancer|March 7, 2013
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group StudyJ L Lesnock, K M Darcy, C Tian, et al.
Australian and New Zealand Journal of Public Health|July 27, 2002
Food availability, cost disparity and improvement in relation to accessibility and remoteness in QueenslandAmanda J Lee, Anna M Darcy, Dympna Leonard, et al.
Gynecologic Oncology|November 13, 2025
Pathogenic germline variants among patients with ovarian cancer by self-reported ancestry: A commercial laboratory collaborative research registry studyChinmayi Aryasomayajula, Caitlin R Johnson, Alex A Francoeur, et al.
JAMA Network Open|October 22, 2025
Trial Enrollment and Survival Disparities Among Patients With Advanced Epithelial Ovarian CarcinomaCaitlin Ruth Johnson, Alex A Francoeur, Amandeep Grewal, et al.
Journal of Alzheimer'S Disease : JAD|April 16, 2016
Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing DatabaseHeather E Barry, Janine A Cooper, Cristín Ryan, et al.
Gynecologic Oncology|August 29, 2009
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group studyCarol Aghajanian, John A Blessing, Kathleen M Darcy, et al.
Gynecologic Oncology|December 27, 2008
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyLeslie M Randall, Bradley J Monk, Kathleen M Darcy, et al.
Pageof 23

Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|November 27, 2007
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancerGillian Thomas, Shamshad Ali, Frank J P Hoebers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Trends in the incidence and mutational landscape of advanced uterine cancerAlex A Francoeur, Cheng-I Liao, Caitlin R Johnson, et al.
British Journal of Cancer|January 10, 2013
Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group StudyS Y Liao, W H Rodgers, J Kauderer, et al.
British Journal of Cancer|March 7, 2013
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group StudyJ L Lesnock, K M Darcy, C Tian, et al.
Australian and New Zealand Journal of Public Health|July 27, 2002
Food availability, cost disparity and improvement in relation to accessibility and remoteness in QueenslandAmanda J Lee, Anna M Darcy, Dympna Leonard, et al.
Gynecologic Oncology|November 13, 2025
Pathogenic germline variants among patients with ovarian cancer by self-reported ancestry: A commercial laboratory collaborative research registry studyChinmayi Aryasomayajula, Caitlin R Johnson, Alex A Francoeur, et al.
JAMA Network Open|October 22, 2025
Trial Enrollment and Survival Disparities Among Patients With Advanced Epithelial Ovarian CarcinomaCaitlin Ruth Johnson, Alex A Francoeur, Amandeep Grewal, et al.
Journal of Alzheimer'S Disease : JAD|April 16, 2016
Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing DatabaseHeather E Barry, Janine A Cooper, Cristín Ryan, et al.
Gynecologic Oncology|August 29, 2009
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group studyCarol Aghajanian, John A Blessing, Kathleen M Darcy, et al.
Gynecologic Oncology|December 27, 2008
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyLeslie M Randall, Bradley J Monk, Kathleen M Darcy, et al.
Pageof 23